ZURAZura Bio Ltdvs its industry peers
A metric-by-metric comparison of Zura Bio Ltd against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ZURAThis | $384M#7 | — | 3.8x#8 | — | — | -31.0%#12 | — | -67.6%#9 | — | — | 15.7%#5 | — |
| CADL | $671M#1 | — | 5.3x#10 | 5368.5x#7 | 0.0%#7 | 30.8%#4 | -38612.8%#8 | -30.3%#3 | — | — | 70.6%#3 | — |
| AURA | $663M#2 | — | 2.1x#7 | — | — | -22.2%#9 | — | -33.7%#4 | — | — | 12.9%#6 | — |
| FDMT | — | — | — | — | 230194.6%#1 | 12.9%#7 | -187.2%#3 | -34.4%#5 | -44.7%#2 | — | 11.9%#7 | — |
| GRML | $629M#3 | — | 10.9x#12 | — | — | -71.6%#13 | — | -18.2%#2 | -14.6%#1 | — | -83.3%#14 | — |
| RGNX | $514M#4 | — | 7.2x#11 | 3.0x#2 | 104.5%#3 | 14.6%#6 | -94.6%#2 | -270.2%#12 | — | — | -32.4%#13 | — |
| EDIT | $412M#5 | — | 3.9x#9 | 10.2x#4 | 25.4%#4 | 32.5%#3 | -394.9%#6 | -152.0%#11 | — | — | -3.2%#10 | — |
| ALLO | $402M#6 | — | 0.9x#1 | — | -100.0%#9 | 25.9%#5 | — | -43.8%#7 | — | — | 6.4%#8 | — |
| TECX | $380M#8 | — | 1.7x#4 | — | — | -27.9%#11 | — | -33125.9%#13 | -713.5%#5 | — | — | — |
| CCCC | $378M#9 | — | 1.5x#3 | 10.5x#5 | 1.0%#6 | 0.3%#8 | -320.5%#5 | -42.5%#6 | — | — | 36.4%#4 | — |
| SRZN | $362M#10 | — | — | 104.1x#6 | -67.4%#8 | -280.8%#15 | -1210.6%#7 | — | — | — | 120.1%#1 | — |
| KYTX | $318M#11 | — | 1.9x#5 | — | — | -26.5%#10 | — | -97.4%#10 | -107.1%#3 | — | -18.6%#11 | — |
| SCTX | $311M#14 | — | — | — | — | — | — | — | — | — | — | — |
| AGEN | $312M#13 | 2.3x#2 | — | 2.7x#1 | 10.4%#5 | 98.7%#2 | -17.7%#1 | — | — | — | 85.8%#2 | — |
| XFOR | $312M#12 | 2.2x#1 | 2.0x#6 | 8.9x#3 | 1273.2%#2 | -111.5%#14 | -247.4%#4 | -50.9%#8 | -582.0%#4 | — | -20.3%#12 | — |
| SABS | $299M#15 | 13.7x#3 | 1.4x#2 | — | -100.0%#9 | 138.9%#1 | — | 6.2%#1 | — | — | 1.1%#9 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice